Skip to main content
graph.swiss

Sika AG

XSWX:SIKA
192,85-2,65(-1.36%)
ACHAT
Généré le 31 juil. 2026
Analyse IA
XSWXSIKACommon StockBasic Materials

Sika AG

192,85
-2,65(-1.36%)
XSWX:SIKA
Fourchette de négoce sur 52 semaines
Cap. bours.

31.37B

Volume 24 h

298.90K

Plus haut 52 sem.

245,50

Plus bas 52 sem.

120,35

Ratio C/B

27.75

BPA

N/A

Marge bénéficiaire

9.4%

Bêta

1.19

Tableau des signaux

ACHAT
Sentiment
+42Haussier
-1000+100

Near-term price action will likely hinge on follow-through from the Q2 2026 earnings beat and raised guidance, both of which have driven a powerful rally over the past several weeks. Investors should watch whether the stock can hold above the CHF 175-180 zone without a sharp retracement, given RSI readings near overbought and Bollinger Band positioning suggesting near-term overextension. The EU antitrust investigation remains a wildcard that could trigger renewed volatility if news flow intensifies. On balance, the combination of positive fundamental momentum and stretched short-term technical

Catalyseurs

Raised FY2026 growth guidanceSika raised its full-year local-currency revenue growth guidance to 3%-6% after delivering 4.0% local-currency growth in H1 2026, a strong signal of resilience in weak construction markets.
EU antitrust investigation escalationThe European Commission has stepped up its cartel probe into eight construction chemicals firms, including Sika, over alleged price-fixing during 2021-2022, a risk that previously drove shares to a one-month low.
Q2 2026 earnings beatSika reported EPS of 1.59 versus an estimate of 1.56 (a 1.92% surprise), contributing to a rally that saw shares gain roughly 23.8% over the trailing 90 days per market commentary.
Margin squeeze concerns post-rallyAnalyst commentary (Simply Wall St) flagged that Sika's stock rally is running into questions about full valuation and margin pressure even as sales outlook improves.
1,500-position cost-cutting programSika announced structural job cuts to defend margins amid weak markets such as China, a move that could support profitability longer-term but signals near-term demand softness.

Tableau de bord synthétique

SentimentHaussier
Niveau de risqueModéré (48)
ValorisationSurévaluée
CroissanceNégative
Santé fin.Modérée
Tendancehaussier
Base CT+0.92%
Base MT+1.75%
Chiffres clés
C/B27.8
ROE16.0%
D/E1.27
Analyse IA
Assez récent(il y a 6 j)
31 juil. 2026

Question clé

Can Sika's improving top-line momentum and cost-cutting initiatives translate into sustained margin recovery quickly enough to justify a valuation that already sits near multi-year highs, especially with an unresolved EU antitrust investigation hanging over the stock?

Scénario haussier

Sika has just demonstrated resilience with 4.0% local-currency H1 2026 revenue growth in a challenging European construction environment, prompting management to raise full-year guidance to 3%-6% growth — a rare positive signal among building materials peers. The company's scale advantages from the Parex and MBCC acquisitions, its global footprint across 102 countries, and strong returns on equity (16.04%) underpin a durable competitive moat in specialty construction chemicals. Free cash flow generation of CHF 1.33 billion in the latest fiscal year provides ample flexibility to fund the growing dividend, deleverage, and invest in efficiency initiatives like Fast Forward. If margin recovery from cost-cutting materializes alongside the improved top-line trajectory, the stock could re-rate to

Scénario baissier

Trailing metrics remain weak, with quarterly revenue down 4.78% YoY and quarterly EPS down 16.2% YoY, suggesting the recent guidance raise has not yet shown up meaningfully in reported results. The stock's valuation — 27.75x trailing earnings and 17.69x EV/EBITDA — already prices in a substantial recovery, leaving limited margin for disappointment, particularly with RSI near overbought at 69.4 following a 25% three-month rally. The escalating EU antitrust investigation into alleged price-fixing among construction chemicals firms represents a real regulatory overhang that could result in material fines or reputational damage. Additionally, the balance sheet carries CHF 14.07 billion of goodwill against total equity of just CHF 6.67 billion, exposing the company to impairment risk if the MBC

Aperçu de la société

Basic MaterialsSpecialty ChemicalsSwitzerland33'856 collaborateursCEO : Mr. Ahmed Khaled El-Hoshy
sika.com41 58 436 68 00Zugerstrasse 50, Baar, Switzerland
Sika AG is a Swiss multinational specialty chemicals company headquartered in Baar, Switzerland, renowned for its globally leading position in developing and producing systems and products for bonding, sealing, damping, reinforcing, and protecting. Founded in 1910 by Kaspar Winkler, who invented the iconic Sika-1 waterproofing agent used in the Gotthard Tunnel, the company has evolved into a key player serving the building sector and industrial manufacturing, particularly construction, automotive, transportation, marine, and renewable energy industries. With subsidiaries in 102 countries, over 400 factories, and more than 33,856 full-time employees, Sika generated TTM revenue of CHF 11.20 billion. The company's innovative solutions, including brands like Sikaflex, SikaBond, and ViscoCrete, enhance the durability of structures against harsh conditions, optimize manufacturing processes, and support sustainability transitions in construction and transportation. Strategic acquisitions such as Parex in 2019 and MBCC Group in 2023 have significantly bolstered Sika's portfolio across the construction lifecycle and materially expanded its goodwill and intangible asset base, reinforcing the company's scale advantage even as it works through integration. Under CEO Ahmed Khaled El-Hoshy, Sika continues to drive innovation through patents, global technology centers, and efficiency programs such as the Fast Forward initiative launched in 2025, aimed at streamlining operations and restoring margin momentum amid a challenging European construction backdrop.

Position sur le marché

As a global leader in construction chemicals and industrial bonding, sealing, and reinforcing solutions, Sika holds a differentiated market position built on more than a century of brand recognition, an extensive patent portfolio, and a manufacturing footprint spanning over 400 factories across 102 countries. The Parex and MBCC acquisitions have materially expanded Sika's addressable market across the full construction lifecycle, positioning the company to outperform underlying market growth even in soft demand environments, as evidenced by its 4.0% local-currency H1 2026 growth against a backdrop of weak European construction activity. This scale advantage is not without scrutiny, however, as the ongoing EU antitrust investigation into pricing behavior among construction chemicals firms highlights the concentrated, oligopolistic nature of the industry — a dynamic that has historically supported strong margins but now attracts regulatory attention.

Perspectives

The near-term investment case hinges on whether Sika's raised full-year guidance and H1 2026 outperformance mark a genuine inflection point after a period of trailing revenue and earnings contraction. Key catalysts to watch include forthcoming quarterly results confirming the guided 3%-6% growth trajectory, progress on the Fast Forward margin-recovery program, and resolution — or escalation — of the EU antitrust probe. With the stock already up roughly 25% over the trailing three months and trading near the top of its 52-week range, much of the near-term good news appears priced in, suggesting a more balanced risk/reward profile going forward. Investors with a constructive multi-year view on Sika's competitive positioning may find pullbacks toward the 50-day moving average (CHF 159.64) more attractive entry points than chasing the current rally.

Analyse fondamentale

ValorisationCroissancePerformanceSanté fin.Dividendes255075
Valorisation
Surévaluée
Croissance
Négative
Performance
Modérée
Santé fin.
Modérée
Dividendes
Durable

Évaluations détaillées

Valorisation
Surévaluée

Sika trades at a trailing P/E of 27.75x and EV/EBITDA of 17.69x, both rich for a specialty chemicals company facing a declining quarterly revenue trend (-4.78% YoY). The forward P/E of 21.89x implies the market is pricing in a meaningful earnings recovery, while the price-to-book ratio of 4.23x versus a book value per share of CHF 41.55 suggests investors are paying a substantial premium over tangible net asset value, largely justified by the company's goodwill-heavy, brand-driven business model built through M&A.

Croissance
Négative

Quarterly earnings growth YoY of -16.2% and quarterly revenue growth YoY of -4.78% point to a near-term contraction in the underlying business, consistent with a weak European construction backdrop. However, management's July 2026 announcement raising full-year local-currency revenue growth guidance to 3%-6% and reporting 4.0% local currency growth in H1 suggests an inflection is underway that the trailing figures do not yet fully capture.

Performance passée
Modérée

Annual sales grew steadily from CHF 9.25 billion in 2022 to CHF 11.76 billion in 2025, driven heavily by the transformative MBCC Group acquisition, while EBITDA expanded from CHF 1.76 billion to over CHF 2.3 billion over the same period. Free cash flow has remained consistently positive (CHF 833.8 million to CHF 1.43 billion annually), though the most recent TTM period shows a slight pullback in both sales (CHF 11.20 billion) and EBITDA (CHF 2.09 billion), reflecting integration costs and a softer demand environment.

Santé financière
Modérée

The balance sheet carries meaningful leverage, with total liabilities of CHF 8.48 billion against shareholders' equity of CHF 6.67 billion, implying a debt-to-equity ratio of approximately 1.27x, and a current ratio of 1.25x indicating adequate but not abundant short-term liquidity. Goodwill of CHF 14.07 billion dominates the CHF 15.15 billion asset base, a legacy of the Parex and MBCC acquisitions, which elevates impairment risk but is offset by robust EBITDA generation of CHF 2.09 billion and healthy return on equity of 16.04%.

Dividendes
Durable

Sika's payout ratio of 57.1% leaves ample room for reinvestment while maintaining shareholder returns, and free cash flow of CHF 1.33 billion in the latest fiscal year comfortably covers the CHF 288.8 million paid in dividends. The forward annual dividend rate of CHF 14.8 versus a trailing rate of CHF 3.7 shows a notable step-up, and combined with consistent multi-year free cash flow generation, the dividend appears well-supported by underlying cash generation.

Indicateurs clés

Ratio C/B

27.75

Marge bénéficiaire

9.4%

ROE

16.0%

Ratio D/E

1.27

Ratio de liquidité

1.25

Analyse de valorisation

Comment le marché valorise cette action par rapport à ses fondamentaux.

Ratio C/B

Multiple cours/bénéfice

27.75
C/B prospectif

C/B futur attendu

21.89
Cours/Valeur comptable

Cours par rapport à la valeur comptable

4.23
Cours/CA

Cours par rapport au chiffre d'affaires

2.60
VE/EBITDA

Valeur d'entreprise par rapport à l'EBITDA

17.69

Analyse

Sika trades at a trailing P/E of 27.75x and a forward P/E of 21.89x, with the discount between the two multiples signaling market expectations for earnings recovery over the next twelve months. The EV/EBITDA multiple of 17.69x and price-to-sales ratio of 2.60x are both elevated relative to typical specialty chemicals sector ranges, which often trade in the low-to-mid teens on EV/EBITDA, reflecting the premium the market assigns to Sika's brand strength, scale, and margin profile. The price-to-book ratio of 4.23x, against a book value per share of CHF 41.55, further underscores that investors are paying well above net asset value, a stance justified only if the company's recently raised growth guidance translates into durable earnings expansion. Whether this valuation is justified depends heavily on execution against the newly raised 3%-6% full-year growth guidance. Given that trailing quarterly revenue and earnings are currently contracting (-4.78% and -16.2% YoY respectively), the current multiples appear to price in a meaningful inflection that has not yet fully materialized in reported numbers, creating valuation risk if the recovery narrative falters.

Croissance & rentabilité

Sika's growth trajectory presents a study in contrasts: multi-year revenue has expanded from CHF 9.25 billion in 2022 to a peak of CHF 11.76 billion in 2025, driven substantially by the transformative MBCC Group acquisition, yet the most recent trailing twelve-month figures show revenue softening to CHF 11.20 billion, a 4.78% YoY quarterly decline. Quarterly EPS growth of -16.2% YoY reinforces that near-term earnings momentum has decelerated, consistent with commentary about weak European and Chinese construction demand. However, the growth picture may be inflecting positively: management's July 2026 disclosure of 4.0% local-currency H1 2026 revenue growth, alongside the decision to raise full-year growth guidance to 3%-6%, suggests the trailing contraction may represent a trough rather than a sustained trend. Investors should monitor upcoming quarterly reports closely to confirm whether this guidance translates into an actual reacceleration in reported figures.

Sika delivers a TTM profit margin of 9.37% and operating margin of 14.26%, alongside a strong return on equity of 16.04% and return on assets of 6.04%. These figures point to a business with solid pricing power and operational leverage, even as absolute profitability has compressed slightly from the CHF 2.30 billion EBITDA recorded in fiscal 2025 to CHF 2.09 billion on a trailing basis. The gap between operating margin (14.26%) and net profit margin (9.37%) reflects meaningful interest expense (CHF 157.9 million in the latest fiscal year) tied to acquisition-related debt, underscoring how the M&A-driven growth strategy has come with a financing cost that dilutes bottom-line profitability. The ongoing Fast Forward efficiency program and 1,500-position job reduction appear aimed directly at narrowing this gap and restoring margin trajectory.

Croissance

Croissance du CA (sur un an)-4.8%
Croissance du BPA (trim.)-16.2%
CA/action$69.82

Rentabilité

Marge bénéficiaire9.4%
Marge opérationnelle14.3%
Rendement des fonds propres16.0%
Rendement des actifs6.0%

Solidité financière

Sika's balance sheet shows total liabilities of CHF 8.48 billion against total shareholders' equity of CHF 6.67 billion, implying a debt-to-equity ratio of approximately 1.27x — a moderate leverage level for a company that has funded large acquisitions with debt. The current ratio of 1.25x indicates adequate, though not abundant, short-term liquidity, with total current assets of CHF 4.41 billion covering total current liabilities of CHF 3.53 billion. Cash and short-term investments stood at CHF 801.8 million as of the latest balance sheet date, while EBITDA of CHF 2.09 billion provides solid coverage for debt servicing. The dominant balance sheet feature is goodwill of CHF 14.07 billion, comprising roughly 93% of the CHF 15.15 billion in total assets — a legacy of the Parex and MBCC transactions that, while supporting Sika's scale and market position, exposes the company to impairment risk if integration underperforms or if end markets deteriorate further. Capital allocation has favored a mix of dividends (CHF 288.8 million paid in the latest fiscal year), continued M&A, and modest share buybacks.

Endettement (D/E)

Dette totale par rapport aux fonds propres

1.27
Ratio de liquidité

Capacité à couvrir les engagements à court terme

1.25
EBITDA

Bénéfice avant intérêts, impôts et amortissements

2.09B
Valeur comptable/action

Actif net par action

$41.55

Instantané technique

Principaux indicateurs techniques et signaux de cours.

Tendance

haussier

Bêta

1.19

Croisement de MM

Croix dorée

Cours vs MM 50

au-dessus

Cours vs MM 200

au-dessus

Support / Résistance

162,25183,00

Sika's technical picture is constructively bullish following a sharp rally from the low-CHF 130s in early April to nearly CHF 180 by late July, with price now trading well above both the 50-day (CHF 159.64) and 200-day (CHF 153.73) moving averages. Momentum indicators broadly confirm the uptrend, with MACD firmly positive and RSI at 69.4 flagging the stock as approaching, but not yet in, overbought territory. However, ADX of just 22.0 suggests the trend, while positive, lacks powerful directional conviction, and price is pressing against the upper Bollinger Band (CHF 180.40), which often precedes a consolidation phase. Investors should watch for a potential pause or pullback toward the CHF 162-168 zone before further gains, while a break above CHF 183-190 would confirm continuation toward

Dividendes

Durable

Sika's payout ratio of 57.1% leaves ample room for reinvestment while maintaining shareholder returns, and free cash flow of CHF 1.33 billion in the latest fiscal year comfortably covers the CHF 288.8 million paid in dividends. The forward annual dividend rate of CHF 14.8 versus a trailing rate of CHF 3.7 shows a notable step-up, and combined with consistent multi-year free cash flow generation, the dividend appears well-supported by underlying cash generation.

Questions fréquentes

Questions fréquentes sur Sika AG, avec réponses issues de l'analyse IA

Sika presents a mixed picture: the stock has rallied roughly 25% over the past three months on the back of a raised full-year growth guidance and a Q2 2026 earnings beat, but it now trades at a trailing P/E of 27.75x and a forward P/E of 21.89x, valuations that appear to already price in a recovery. Investors need to weigh the recent momentum against decelerating trailing revenue growth (-4.78% YoY) and an ongoing EU antitrust probe. The stock is technically strong but sits near overbought territory with an RSI of 69.4, suggesting near-term caution is warranted even for those constructive on the longer-term story.

Yes. Sika's forward annual dividend rate is CHF 14.8 per share against a payout ratio of 57.1%, which is well covered by free cash flow of CHF 1.33 billion generated in the most recent fiscal year against CHF 288.8 million in dividends paid. The trailing annual dividend rate stood at CHF 3.7 per share, indicating a meaningful step-up planned in the forward dividend. The dividend appears sustainable given the company's consistent multi-year free cash flow generation.

Sika's TTM profit margin is 9.37%, with an operating margin of 14.26%, return on equity of 16.04%, and return on assets of 6.04%. These figures reflect a company generating solid returns on shareholder capital despite carrying a large asset base inflated by acquisition-related goodwill. EBITDA of CHF 2.09 billion on TTM revenue of CHF 11.20 billion implies an EBITDA margin of roughly 18.6%, consistent with a well-established specialty chemicals franchise.

Sika shares climbed sharply after the company reported first-half 2026 results showing 4.0% local-currency revenue growth and delivered an EPS beat (actual EPS of 1.59 vs. estimate of 1.56, a 1.92% surprise), prompting management to raise its full-year revenue growth guidance to 3%-6%. This came against a backdrop of a broadly weak European construction market, making the outperformance particularly notable to investors, as reflected in a roughly 23.8% ninety-day price gain noted by market commentary.

The most prominent near-term risk is the European Commission's antitrust investigation into alleged price-fixing among construction chemicals firms covering the 2021-2022 period, which has already weighed on shares. Beyond regulatory risk, trailing revenue (-4.78% YoY) and earnings (-16.2% YoY) growth remain negative, the balance sheet carries CHF 14.07 billion of goodwill from major acquisitions, and the stock's current valuation (27.75x trailing earnings) leaves little room for error if the guided recovery falters.

At a current price of CHF 179.85, Sika trades near the top of its 52-week range of CHF 120.35 to CHF 199.95, sitting at approximately the 75th percentile of that range. The stock's forward P/E of 21.89x is meaningfully below its trailing P/E of 27.75x, reflecting analyst expectations of earnings recovery, while the EV/EBITDA multiple of 17.69x suggests the market continues to award Sika a premium relative to the current earnings base.

Sika's balance sheet shows total liabilities of CHF 8.48 billion against total shareholders' equity of CHF 6.67 billion (debt-to-equity of approximately 1.27x), with a current ratio of 1.25x indicating adequate but modest short-term liquidity. Cash and equivalents stood at CHF 801.8 million as of the latest balance sheet date, and EBITDA of CHF 2.09 billion provides solid coverage for debt-servicing needs, though the goodwill-heavy asset base (CHF 14.07 billion) is a factor to monitor for future impairment risk.

Sika trades well above both its 50-day moving average (CHF 159.64) and 200-day moving average (CHF 153.73), a bullish alignment reinforced by a positive MACD reading (3.18 vs. a 1.18 signal line). However, RSI at 69.4 is approaching overbought territory and the price sits just below the upper Bollinger Band (CHF 180.40), suggesting the recent sharp rally may need to consolidate before extending further, especially with ADX at only 22.0 signaling a moderate rather than powerful trend.

Avertissement important

Les informations fournies sur cette page le sont à titre purement informatif et ne constituent ni un conseil en investissement, ni un conseil financier, ni un conseil de négoce, ni aucune autre forme de conseil. Vous ne devez traiter aucun de ces contenus comme tel. Graph.world ne recommande ni l'achat, ni la vente, ni la détention de titres. Effectuez toujours vos propres vérifications et consultez un conseiller financier agréé avant toute décision d'investissement.